Studies show around 18.3% body weight lost at 12 months and mean losses as high as 25.5% at 18 months for specific responders
This curve exists because: Appetite resets at a lower level Your baseline hunger is suppressed, but your body recalibrates its energy balance signals Resting metabolic rate decreases A lighter body burns fewer calories at rest, even without any change in habits Muscle mass may decline Without adequate protein and resistance exercise, up to 40% of weight lost can come from lean tissue, further suppressing metabolism Dose ceiling effects emerge Many patients on a stable dose reach the therapeutic maximum for their current titration level "A GLP-1 plateau is your body asking for a more complete strategy not a sign that treatment has failed
From Alzheimers (a disease with no known cure) to depression (a disease where many patients are considered treatment-resistant), there is much work to be done
Tirzepatide versus Semaglutide once Weekly in Type 2 diabetes
Even though patients with RA showed higher plasma levels of superoxide dismutase (another of the bodys super antioxidants), they also had high levels of pro-oxidants, and increased nitric oxide, an inflammatory marker